Literature DB >> 8385036

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.

H U Häring1, H Mehnert.   

Abstract

Insulin resistance of skeletal muscle, liver and fat combined with an abnormality of insulin secretion characterizes Type 2 (non-insulin-dependent) diabetes mellitus. There is increasing evidence that the insulin resistance of the skeletal muscle plays a key role early in the development of Type 2 diabetes. As a consequence recent research efforts have focussed on the characterization of insulin signal transduction elements in the muscle which are candidates for a localization of a defect causing insulin resistance i.e. the insulin receptor, phosphatases related to insulin action, glycogen synthase and the glucose transporters. In this review we attempt to summarize present knowledge about abnormalities of these systems in skeletal muscle of Type 2 diabetic and pre-diabetic individuals. We try to classify abnormalities as secondary events or as candidates for putative primary molecular defects which might initiate the development of insulin resistance as early as in the "pre-diabetic" state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385036     DOI: 10.1007/bf00399946

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  69 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.

Authors:  C Schalin-Jäntti; M Härkonen; L C Groop
Journal:  Diabetes       Date:  1992-05       Impact factor: 9.461

3.  Further evidence for a two-step model of glucose-transport regulation. Inositol phosphate-oligosaccharides regulate glucose-carrier activity.

Authors:  B Obermaier-Kusser; C Mühlbacher; J Mushack; E Seffer; B Ermel; F Machicao; F Schmidt; H U Häring
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

4.  Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.

Authors:  B L Nyomba; V M Ossowski; C Bogardus; D M Mott
Journal:  Am J Physiol       Date:  1990-06

5.  Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.

Authors:  S M Haffner; M P Stern; H P Hazuda; J A Pugh; J K Patterson
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

6.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus.

Authors:  B Obermaier-Kusser; M F White; D E Pongratz; Z Su; B Ermel; C Muhlbacher; H U Haring
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

7.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Damsbo; A Vaag; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

8.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.

Authors:  G R Freidenberg; D Reichart; J M Olefsky; R R Henry
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Blood pressure, insulin, and glycemia in nondiabetic subjects.

Authors:  A M Fournier; M T Gadia; D B Kubrusly; J S Skyler; J M Sosenko
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

Review 10.  Mutations in insulin-receptor gene in insulin-resistant patients.

Authors:  S I Taylor; T Kadowaki; H Kadowaki; D Accili; A Cama; C McKeon
Journal:  Diabetes Care       Date:  1990-03       Impact factor: 19.112

View more
  14 in total

Review 1.  Oxidative stress and insulin action: is there a relationship?

Authors:  G Paolisso; D Giugliano
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

2.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

3.  Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy.

Authors:  K Ueki; T Yamauchi; H Tamemoto; K Tobe; R Yamamoto-Honda; Y Kaburagi; Y Akanuma; Y Yazaki; S Aizawa; R Nagai; T Kadowaki
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

4.  Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women.

Authors:  Olga Carlson; Bronwen Martin; Kim S Stote; Erin Golden; Stuart Maudsley; Samer S Najjar; Luigi Ferrucci; Donald K Ingram; Dan L Longo; William V Rumpler; David J Baer; Josephine Egan; Mark P Mattson
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

5.  Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.

Authors:  M Bähr; M Spelleken; M Bock; M von Holtey; R Kiehn; J Eckel
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

6.  Regulation of human insulin receptor RNA splicing in vivo.

Authors:  S Norgren; J Zierath; A Wedell; H Wallberg-Henriksson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 8.  Modulation of insulin receptor signalling: significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation.

Authors:  H U Häring; M Kellerer; L Mosthaf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

9.  Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.

Authors:  K Malminiemi
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

10.  Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.

Authors:  M P Coghlan; T S Pillay; J M Tavaré; K Siddle
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.